Company news
Heartbeam, Inc. (NASDAQ:BEAT) news
Every Heartbeam, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
HeartBeam to Host Second Quarter 2026 Results Conference Call on Thursday, August 13, 2026 at 4:30 p.m. Eastern Time
July 30, 2026
HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device
July 14, 2026
HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule
July 1, 2026
HeartBeam (BEAT) Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study
June 30, 2026
HeartBeam (BEAT) Reorganizes to Accelerate Global Commercialization Strategy
June 25, 2026
HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition
June 24, 2026
HeartBeam (NASDAQ: BEAT) Launches Study Focused on Testing Proprietary Patch Capable of Generating On-Demand 12-Lead ECG for Ischemia Det...
June 23, 2026
HeartBeam (BEAT) Study Shows Portable ECG Device Can Help Identify Heart Attack Risk
June 3, 2026
HeartBeam Announces New Peer-Reviewed Article Demonstrating Potential to Help Identify Heart Attack Risk at Home
June 2, 2026
HeartBeam (BEAT) Aims to Close Critical Gap in Early Cardiac Detection
May 26, 2026
HeartBeam (NASDAQ: BEAT) Advances Commercial Launch, Reports First-Quarter 2026 Results
May 14, 2026
HeartBeam Reports First Quarter 2026 Results
May 13, 2026
HeartBeam Initiates Pilot Study of First On-Demand 12-Lead ECG Patch to Detect Ischemia Outside the Clinic
May 11, 2026
HeartBeam Expands Commercial Presence Across Four Key U.S. Markets with Addition of Premier Concierge Practice
May 7, 2026
HeartBeam (BEAT) to Host Q1 2026 Earnings Call and Provide Strategic Updates
April 30, 2026
HeartBeam (BEAT) Closes $10M Public Offering to Advance Cardiac Technology Commercialization
April 17, 2026
HeartBeam Announces Closing of $10 Million Public Offering of Common Stock
April 16, 2026
HeartBeam (BEAT) Launches Proposed Public Offering to Support Commercialization and AI Initiatives
April 15, 2026
HeartBeam Announces Proposed Public Offering of Common Stock
April 14, 2026
HeartBeam Announces Pricing of $10 Million Public Offering of Common Stock
April 14, 2026
HeartBeam (BEAT) Partners With Mount Sinai to Accelerate AI-ECG Development and Validation
March 25, 2026
HeartBeam : Earnings Documents
March 20, 2026
HeartBeam (BEAT) Reports Q4 and Full-Year 2025 Results, Advances Commercialization and Clinical Development
March 13, 2026
HeartBeam Reports Fourth Quarter and Full Year 2025 Results
March 12, 2026
HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home
March 10, 2026
HeartBeam to Attend Investor and Industry Conferences in March, Focused on Providing Updates on Commercial Launch and Unveiling 12-Lead E...
March 9, 2026
HeartBeam Announces First Patient Enrollments in Heart Attack Detection Pilot Study
March 5, 2026
HeartBeam to Host Fourth Quarter Full Year 2025 Results Conference Call on Thursday, March 12, 2026 at 4:30 p.m. Eastern Time
March 4, 2026
HeartBeam Announces First Commercial Customer as ClearCardio Brings Groundbreaking 12-Lead ECG Technology to High-Growth Preventive Cardi...
March 4, 2026
HeartBeam (BEAT) Highlighted Among Medical Device Innovators as FDA Clearances Set Tone for New Year
February 13, 2026
HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer
January 22, 2026
HeartBeam to Attend JP Morgan 2026 Annual Healthcare Conference
January 5, 2026
HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment
December 10, 2025
HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application
November 26, 2025
HeartBeam (BEAT) Reports Q3 2025 Results as FDA Review Nears Completion and Commercial Readiness Accelerates
November 14, 2025
HeartBeam Reports Third Quarter 2025 Results
November 13, 2025
HeartBeam to Host Third Quarter 2025 Results Conference Call on Thursday, November 13, 2025 at 4:30 p.m. Eastern Time
October 30, 2025
HeartBeam Teams Up With HeartNexus to Deliver Cardiologist-Level ECG Insights Anytime, Anywhere
October 28, 2025
HeartBeam (BEAT) Reports Study Showing Comparable Accuracy Between HeartBeam System and Standard 12-Lead ECG in Detecting Arrhythmias
September 9, 2025
HeartBeam’s Deep Learning Algorithms Demonstrate High Rates of Accuracy for Detecting Arrhythmias
September 8, 2025
HeartBeam (NASDAQ: BEAT) to Present at Three September Investor Conferences
August 29, 2025
HeartBeam to Participate at Upcoming Industry and Investor Conferences, September 4-10, 2025
August 28, 2025
HeartBeam's (NASDAQ: BEAT) IP Momentum Continues with New Patents Advancing 3D ECG Technology
August 22, 2025
HeartBeam Reports Second Quarter 2025 Results
August 13, 2025
HeartBeam to Host Second Quarter 2025 Results Conference Call on Wednesday, August 13, 2025 at 4:30 p.m. Eastern Time
July 30, 2025
HeartBeam Wins Industry Innovation Award for Advancing Remote Cardiac Care With Groundbreaking ECG Technology
July 22, 2025
HeartBeam to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24, 2025
June 17, 2025
HeartBeam Reports First Quarter 2025 Results
May 13, 2025
HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio
May 6, 2025
HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth
May 5, 2025